InsidersTradesSigma
한독 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 한독 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 한독 has recorded 26 insider filings. The latest transaction was filed on 18 June 2026 (Other). Among the most active insiders: 김영진. All data is accessible without an account.
26
Insider Decl.
0
Thresholds
€282,242
5 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 June 2026
Declarations26 total
56,676 shares@ ₩8,800.00100.0% of flowShareKRXDART:20260604000304
Ideal exit: 26 Feb 2027 (T+270)
25 of 26 declarations
About 한독
HanDoc is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.